Inspire Medical Systems (INSP) has posted standout numbers once again, with revenue on track to climb 10.7% annually and earnings projected to surge 25.6% per year over the next three years, both ...

CAVA's Q3 revenue came in at $292.24M versus the $291.95M estimate, while EPS missed at $0.12 against a $0.13 consensus.

MILPITAS, Calif., Nov. 4, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp” or the “Company”) (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025. Third ...

Zohran Mamdani could become New York City's first Muslim mayor if he can fend off an upset bid by former Gov. Andrew Cuomo.

Q3 2025 Management View David Steinberg, Co-Founder, Chairman & CEO, stated, "For the 17th quarter in a row, we once again ...

Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...

Strong Q3 2025 led by Registry Operations and resilient, diversified, Services segment; diluted EPS $0.45Company currently on track to hit net leverage target range of 2.0x – 2.5x by 2026Guidance ...

Strong Operating Profit, Up 8% YoY to $400 millionPowered by Same-Store Sales Growth, Accelerated New Store Openings and Margin ExpansionAchieved 11 Consecutive Quarters of Same-Store Transaction ...